DMII (Drugs Made In America Acquisition II) Non Operating Income: $0.00 Mil (TTM As of Mar. 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II Non Operating Income?

Drugs Made In America Acquisition II DMII 15 Non Operating Income is $0.00 Mil as of Mar. 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Drugs Made In America Acquisition II's Non Operating Income for the three months ended in Mar. 2026 was $0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Drugs Made In America Acquisition II Non Operating Income Related Terms

Drugs Made In America Acquisition II Non Operating Income Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition II's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II Non Operating Income Chart

Drugs Made In America Acquisition II Annual Data
Trend Dec24 Dec25
Non Operating Income
0.00 0.55

Drugs Made In America Acquisition II Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Non Operating Income Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of $0.00 Mil mean?
Drugs Made In America Acquisition II (DMII) has a Non Operating Income of $0.00 Mil as of Mar. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Drugs Made In America Acquisition II and its competitors.
Is Drugs Made In America Acquisition II's Non Operating Income too high?
Drugs Made In America Acquisition II's current Non Operating Income is $0.00 Mil. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's Non Operating Income compare to BCSS and EVAC?
Drugs Made In America Acquisition II's Non Operating Income of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Diversified Financial Services company?
A good Non Operating Income depends on the Diversified Financial Services industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current Non Operating Income is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current Non Operating Income of $0.00 Mil. The current Non Operating Income is $0.00 Mil. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current Non Operating Income is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price